Xhance (fluticasone propionate) is a brand-name drug that’s prescribed for chronic rhinosinusitis with or without nasal polyps in adults. Xhance comes as a nasal spray that’s typically used ...

Unlike rhinitis or nasal polyps, which are more responsive to standard ... The Exhalation Delivery System™ with fluticasone ...

YARDLEY, PA — Pharmaceutical company Optinose has outlined an ambitious commercial strategy following the FDA’s recent approval of XHANCE (fluticasone ... without nasal polyps in adults.

(RTTNews) - Optinose, Inc. (OPTN), a pharmaceutical company focused on ear, nose and throat or ENT and allergy, announced Wednesday preliminary XHANCE (fluticasone propionate) net product revenue ...

XHANCE is the first and only approved treatment for patients with chronic rhinosinusitis without nasal polyps (CRSsNP), as well as for those with nasal polyps (CRSwNP). The analysts' optimism is ...